Knopp Biosciences LLC
Pittsburgh, PA · Founded 2010 · CIK 0001497598 · Biotech · Private
Small-molecule drug that activates Kv7.2/3 voltage-gated potassium channels for diabetic neuropathic pain
knoppbio.com →- Grants
- $2.2M
- 1 award
- Sector median: 1
- Raised
- $159M
- 7 Form D · Jan 2021
- 69 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 28 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2010201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $140,000,000 | |
| Private capital raised | Form D · SEC | $30,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $10,250,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $7,572,534 | |
| Private capital raised | Form D · SEC | $1 | |
| Federal grant | Department of Health and Human Services · Phase II · Selective Kv7.2/3 activators for the treatment of neuropathic pain | $2,200,680 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3298 | Ferment Labs, Inc. | — | $900K |
| 3299 | Rhamnolipid, Inc. | — | $1.0M |
| 3300 | Starton Therapeutics Inc. | — | $11M |
| 3301 | Knopp Biosciences LLC | — | $159M |
| 3302 | Hemp Synergistics LLC | — | $1.5M |
| 3303 | Stramsen Biotech, Inc. | — | $5.0M |
| 3304 | Syncromune, Inc. | — | $56M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- C. AdairDirector
- Michael BozikDirector · Executive Officer · Promoter
- Stephen ButtsDirector
- Steve DworetzkyExecutive Officer
- Steven DworetzkyExecutive Officer
- Benjamin GomezDirector
- Valentin GribkoffExecutive Officer
- Gregory HebrankDirector · Executive Officer · Promoter
- Evan IngersollExecutive Officer
- Suresh KhemaniExecutive Officer
- Shane KovacsDirector
- Mark KrestonExecutive Officer
- Frank Lucchino, Jr.Executive Officer
- James MatherExecutive Officer
- Jeffrey McCormickDirector
- Thomas Petzinger Jr.Director · Executive Officer · Promoter
- Thomas Petzinger, Jr.Director · Executive Officer · Promoter
- Calman PrussinExecutive Officer
Patents
- KV7 Channel Activators Compositions And Methods Of Usegranted
- KV7 Channel Activators Compositions And Methods Of Usegranted
- Compositions And Methods For Treating Conditions Related To Elevated Levels Of Eosinophils And/or Basophilsgranted
- Compositions And Methods For Treating Conditions Related To Increased Eosinophilsgranted
- BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORSgranted
- KV7 Channel Activators Compositions And Methods Of Usegranted
- Compositions And Methods For Treating Conditions Related To Elevated Levels Of Eosinophils And/or Basophilsgranted
- Compositions And Methods Of Using (r)-pramipexoleapplication
- BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORSapplication
- IMIDAZO[4,5-B]PYRIDIN-2-YL Amides As KV7 Channel Activatorsgranted
- Compositions And Methods For Treating Plasma Cell Disorders And B-cell Prolymphocytic Disordersgranted
- BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORSgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.